Basic Information
Basic information for TMEM161B-AS1-211-29aa
Peptide Name TMEM161B-AS1-211-29aa
Genome Position chr5:88292579-88292665[+]
Species Human
Peptide Sequence MEICIFIHFCFHGLFSCLNFSWYELFYNL
Peptide Length 29
Unique No (TMEM161B-AS1-215-29aa,TMEM161B-AS1-216-29aa,TMEM161B-AS1-225-29aa,TMEM161B-AS1-227-29aa,TMEM161B-AS1-229-29aa,TMEM161B-AS1-230-29aa,TMEM161B-AS1-237-29aa,TMEM161B-AS1-238-29aa,TMEM161B-AS1-241-29aa,TMEM161B-AS1-245-29aa,TMEM161B-AS1-248-29aa,TMEM161B-AS1-254-29aa,TMEM161B-AS1-257-29aa-1,TMEM161B-AS1-258-29aa)
Grand Average of Hydropathicity 1
Relative Molecular Mass 4142.69
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000512724;TMEM161B-AS1-211
Transcript Length 570
Coding Ability 0.4404
DNA Sequence Corresponding to Peptide ATGGAAATTTGTATCTTCATTCACTTTTGTTTTCATGGACTCTTTTCATGTTTGAACTTTTCATGGTATGAGCTGTTTTATAATCTA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :